Clinical Trial Update: Docetaxel in Treating Patients With Solid Tumors [Phase 2]

View source ↗

Summary

Docetaxel was studied in a Phase 2 trial across multiple solid tumors and has completed the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Head and Neck Cancer
• Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Bladder Cancer, Breast Cancer | Phase 2 | Status: COMPLETED